Abstract:Objective Bipolar disorder (BD) is frequently misdiagnosed as major depressive disorder (MDD), which may lead to inappropriate treatment and poor outcomes. This study aimed to examine prescribing patterns of antidepressants, antipsychotics and mood stabilizers in BD patients misdiagnosed with MDD in China.Methods A total of 1487 patients originally diagnosed with MDD were consecutively screened for diagnostic revision in 13 psychiatric hospitals or psychiatric units of general hospitals in China nationwide. The patients' sociodemographic and clinical characteristics were recorded using a standardized protocol and data collection procedure. The Mini International Neuropsychiatric Interview (MINI) was used to establish DSM-IV diagnoses. Data on psychotropic prescriptions were collected by a review of medical records.Results Three hundred and nine of the 1487 patients (20.8%) fulfilled DSM-IV criteria for BD; 118 (7.9%) for BD-I and 191 (12.8%) for BD-II on the MINI. Of the BD patients (n = 309), 227 (73.5%) received any use of antidepressants, 73 (23.6%) antipsychotics and 33 (10.7%) mood stabilizers. In multiple logistic regression analyses, compared with those with MDD, patients with BD-I were more likely to receive antidepressants (OR 1.7, 95% CI 1.12.8, p = 0.02), antipsychotics (OR 1.6, 95% CI 1.042.5, p = 0.04) and mood stabilizers (OR 3.9, 95% CI 2.17.2, p < 0.001), whereas patients with BD-II were more likely to receive mood stabilizers (OR 2.4, 95% CI 1.34.4, p = 0.003). There was no difference in the use of antidepressants (OR 1.1, 95% CI 0.81.5, p = 0.7) and antipsychotics (OR 1.3, 95% CI 0.91.9, p = 0.2) between BD-II and MDD. In addition, there was no difference between BD-I and BD-II in any use of antidepressants, antipsychotics and mood stabilizers.Conclusions The prescription of antidepressants for BD patients misdiagnosed with MDD is very common, and only a very small proportion of patients received guideline-concordant treatment. Considering the potentially hazardous effects of inappropriate pharmacotherapy in this population, continuing education and training addressing the correct diagnosis of BD and rational use of psychotropic medications are needed in China. Copyright (c) 2012 John Wiley & Sons, Ltd.

Recognition potency of three diagnostic definitions of bipolar disorder in patients with current depressive episode

Hypomanic Symptoms Assessed by the HCL-32 in Patients with Major Depressive Disorder: a Multicenter Trial Across China.

Screening for Bipolar Disorder with the Mood Disorders Questionnaire in Patients Diagnosed As Major Depressive Disorder — the Experience in China

Prescribing Patterns Of Antidepressants, Antipsychotics And Mood Stabilizers In Bipolar Patients Misdiagnosed With Major Depressive Disorder In China

Clinical characteristics for depressive patients with high or low cutoff point according to 32 items hypomania checklist

Recognition validity of bipolarity specifier for bipolar disorders among patients with major depressive episode: BRIDGE-China

Evaluation of Mood Disorder Questionnaire (MDQ) in Patients with Mood Disorders: a Multicenter Trial Across China.

Circulating T-cell Subsets Discrepancy Between Bipolar Disorder and Major Depressive Disorder During Mood Episodes: A Naturalistic, Retrospective Study of 1015 Cases

Latent Profile Analysis of Suicidal Ideation in Chinese Individuals with Bipolar Disorder

Socio-demographic and Clinical Features Between Patients with Bipolar Disorder and Ones with Major Depressive Disorder

Clinical Distinctions in Symptomatology and Psychiatric Comorbidities Between Misdiagnosed Bipolar I and Bipolar II Disorder Versus Major Depressive Disorder

The Use of Mood Disorder Questionnaire and Hypomania Checklist-32 for Screening Bipolar Disorder among Outpatients Diagnosed As Major Depressive Disorder in General Hospital

The Use of 15-Point Hypomanic Checklist in Differentiating Bipolar I and Bipolar II Disorder from Major Depressive Disorder.

Bipolar Diagnosis in China: Evaluating Diagnostic Confidence Using the Bipolarity Index

Characteristics of Unrecognised Bipolar Disorder in Patients Treated for Major Depressive Disorder in China: General Versus Psychiatric Hospitals.

Peripheral biomarkers to differentiate bipolar depression from major depressive disorder: a real-world retrospective study

Biochemical and Endocrine Parameters for the Discrimination and Calibration of Bipolar Disorder or Major Depressive Disorder

Impaired facial emotion recognition in individuals with bipolar disorder

Comparing Screening Abilities of the 33-Item Hypomania Checklist (HCL-33) and the 33-Item Hypomania Checklist External Assessment (HCL-33-EA) for the Detection of Bipolar Disorder

Dissecting Clinical and Biological Heterogeneity in Clinical States of Bipolar Disorder: a 10-Year Retrospective Study from China.

Personality traits influence the effectiveness of hypomania checklist-32 in screening for bipolar disorder